Preliminary findings indicate that elevated GBP6 expression is associated with poor prognosis in cervical cancer patients; however, its underlying molecular mechanisms remain unclear. To elucidate the biological roles of GBP6 in cervical carcinogenesis and progression, we employed cervical cancer cell line models to investigate the relevant molecular mechanisms.